Clinical trial
Real-world Evaluation of the Effectiveness of Immunoglobulin-Histamine Complex; IHC (Histoglob) in the Management of Chronic Urticaria: A Prospective, Multicenter, Observational Study.
NCT07680413 is registered in ClinicalTrials.gov with Bharat Serums and Vaccines Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real-world Evaluation of the Effectiveness of Immunoglobulin-Histamine Complex; IHC (Histoglob) in the Management of Chronic Urticaria: A Prospective, Multicenter, Observational Study.
- Lead sponsor
- Bharat Serums and Vaccines Limited
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2025
- Completion date
- August 3, 2026
- Enrollment
- 660 (actual)
- Sites
- 40
Conditions
As the registry lists them; a condition with its own page is linked.